New pill shows promise against tough cancers and brain tumors

NCT ID NCT06012695

Recruiting now Disease control Sponsor: Novelwise Pharmaceutical Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental oral drug called NBM-BMX in people with advanced solid tumors or newly diagnosed glioblastoma (a type of brain cancer). The drug is given alone for solid tumors or combined with standard treatments (radiation and chemotherapy) for brain cancer. The goal is to find safe doses and see if the drug helps control the disease. About 79 adults will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer cancer glioblastoma neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALIGNANT NEOPLASM MALIGNANT NEOPLASM OF BRAIN

Contacts and locations

Locations

Kaohsiung Medical University Chung-Ho Memorial Hospital
NOT_YET_RECRUITING

Kaohsiung City, 807, Taiwan
Koo Foundation Sun Yat-Sen Cancer Center
RECRUITING

Taipei, 112, Taiwan
Linkou Chang-Gung Memorial Hospital
RECRUITING

Taoyuan City, 333, Taiwan
Taichung Veterans General Hospital
RECRUITING

Taichung, 407, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.